Track topics on Twitter Track topics that are important to you
Chi-Med is setting a course straight for the Chinese FDA after its targeted therapy hit its PFS target ahead of...
Original Article: Boost For Chi-Med As Phase III NET Study Stopped Early On PFS BenefitNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...